Tagged with Rare Diseases

Marc LePage – President & CEO, Genome Canada
Interview: Mirosław Zieliński – President National Forum for the Therapy of Rare Diseases (ORPHAN), Poland
Makoto Suematsu – President, Japan Agency for Medical Research and Development (AMED)
Interview: Rudolf Widmann – CEO and Founder, AOP Orphan, Austria
Interview: Wolfgang Schnitzel – General Manager; Karl-Heinz Hofbauer – Site Lead Vienna, Managing Director (Technical Operations), Shire Austria
Interview: Gianfranco Biliotti – General Manager, Alexion Colombia
Interview: James Lennertz – Group VP and GM (EUMEA), Biomarin, Ireland
Christophe Bourdon – SVP EMEA, Alexion Pharmaceuticals
Interview: Leonardo Torres – General Manager Mexico, Central America & Caribbean, Shire
Interview: Dr. Andrea Michael Meyer – General Manager, Sanofi Genzyme Switzerland
Interview: Patrice Carayon – CEO, Chiesi France
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here